Mohit E - Search Results

1

Peptide/protein vaccine delivery system based on PLGA particles.

Allahyari M, Mohit E. Allahyari M, et al. Among authors: mohit e. Hum Vaccin Immunother. 2016 Mar 3;12(3):806-28. doi: 10.1080/21645515.2015.1102804. Hum Vaccin Immunother. 2016. PMID: 26513024 Free PMC article. Review.

2

Different spectra of therapeutic vaccine development against HPV infections.

Bolhassani A, Mohit E, Rafati S. Bolhassani A, et al. Among authors: mohit e. Hum Vaccin. 2009 Oct;5(10):671-89. doi: 10.4161/hv.5.10.9370. Epub 2009 Oct 28. Hum Vaccin. 2009. PMID: 19684468 Review.

3

Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines.

Mohit E, Hashemi A, Allahyari M. Mohit E, et al. Expert Rev Clin Immunol. 2014 Jul;10(7):927-61. doi: 10.1586/1744666X.2014.916211. Epub 2014 May 28. Expert Rev Clin Immunol. 2014. PMID: 24867051 Review.

4

Chemokine-based immunotherapy: delivery systems and combination therapies.

Mohit E, Rafati S. Mohit E, et al. Immunotherapy. 2012 Aug;4(8):807-40. doi: 10.2217/imt.12.72. Immunotherapy. 2012. PMID: 22947009 Review.

5

Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy.

Taslimi Y, Zahedifard F, Habibzadeh S, Taheri T, Abbaspour H, Sadeghipour A, Mohit E, Rafati S. Taslimi Y, et al. Among authors: mohit e. J Breast Cancer. 2016 Mar;19(1):34-44. doi: 10.4048/jbc.2016.19.1.34. Epub 2016 Mar 25. J Breast Cancer. 2016. PMID: 27066094 Free PMC article.

6

The contribution of NT-gp96 as an adjuvant for increasing HPV16 E7-specific immunity in C57BL /6 mouse model.

Mohit E, Bolhassani A, Zahedifard F, Taslimi Y, Rafati S. Mohit E, et al. Scand J Immunol. 2012 Jan;75(1):27-37. doi: 10.1111/j.1365-3083.2011.02620.x. Scand J Immunol. 2012. PMID: 21916914 Free article.

7

Immunomodulatory effects of IP-10 chemokine along with PEI600-Tat delivery system in DNA vaccination against HPV infections.

Mohit E, Bolhassani A, Zahedifard F, Seyed N, Eslamifar A, Taghikhani M, Samimi-Rad K, Rafati S. Mohit E, et al. Mol Immunol. 2013 Jan;53(1-2):149-60. doi: 10.1016/j.molimm.2012.07.011. Epub 2012 Aug 25. Mol Immunol. 2013. PMID: 22926003

8

Biological delivery approaches for gene therapy: strategies to potentiate efficacy and enhance specificity.

Mohit E, Rafati S. Mohit E, et al. Mol Immunol. 2013 Dec;56(4):599-611. doi: 10.1016/j.molimm.2013.06.005. Epub 2013 Aug 1. Mol Immunol. 2013. PMID: 23911418 Review.

9

Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.

Salehi M, Taheri T, Mohit E, Zahedifard F, Seyed N, Taslimi Y, Sattari M, Bolhassani A, Rafati S. Salehi M, et al. Among authors: mohit e. Immunotherapy. 2012 Nov;4(11):1107-20. doi: 10.2217/imt.12.110. Immunotherapy. 2012. PMID: 23194361

10

Different strategies for expression and purification of the CT26-poly-neoepitopes vaccine in Escherichia coli.

Movahed Z, Sharif E, Ahmadzadeh M, Nezafat N, Jahandar H, Mohit E. Movahed Z, et al. Among authors: mohit e. Mol Biol Rep. 2022 Feb;49(2):859-873. doi: 10.1007/s11033-021-06727-w. Epub 2022 Jan 20. Mol Biol Rep. 2022. PMID: 35059972

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters